Evaluating the potential benefit of interferon treatment in multiple sclerosis

JAMA. 2012 Jul 18;308(3):290-1. doi: 10.1001/jama.2012.8327.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Disabled Persons*
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Interferon-beta / therapeutic use*
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Multiple Sclerosis, Relapsing-Remitting / physiopathology*

Substances

  • Immunologic Factors
  • Interferon-beta